Not just a long distance relationship: immune cells in skin fight off infection better than the restApril 08, 2009Scientists at the University of Melbourne have discovered the local action of immune cells in the skin, which could improve treatment of viral skin infections. This work identifies previously unrecognised first-line defence mechanisms that are particularly important in barrier locations such as the skin and the gut, often used as portals of entry by viruses and bacteria. Researchers examined two aspects of anti-viral immune responses by studying the cells involved in the initial stimulation of the immune response, and the cells that remember past infections to boost the response after reinfection. They did this by using a model infection with herpes simplex virus - a virus best known for causing cold sores but also associated with life threatening diseases in certain individuals and newborns. The work was published in two articles in the advanced online March and April editions of the journal Nature Immunology. The April article details findings on the function of the cells that trigger the initial immune response to viral infection - known as dendritic cells. "Dendritic cells are like police patrolling our blood and tissues for anything unusual. There are many different types of them, so we wanted to examine how they differ in their function," said Dr Sammy Bedoui, from the University of Melbourne's Department of Microbiology and Immunology, who is the lead author on the April paper. Using an animal model of skin infection with the cold sore virus, researchers showed for the first time that a particular type of dendritic cells was responsible for triggering the immune response. These cells do this by presenting virus particles to Killer T cells, which triggers a cascade of immune responses to tackle infection. The results could not only provide help in the treatment of viral skin infections, but also of auto-immune diseases of the skin such as psoriasis, where dendritic cells trigger the immune system to attack the body's own cells. The March paper focuses on the stage after infection has subsided, where some cells retain the ability to recognize the shape of the virus or bacteria - understandably called memory T cells. Again using the animal model of infection with the cold sore virus, researchers found that memory T cells in the skin provide local immunity against pathogens. "Because the cells are located at the site of infection, they can respond instantly, much faster than other immune cells that have to travel via the blood to the site," said Dr Thomas Gebhardt from the University of Melbourne's Department of Microbiology and Immunology, who is the lead author on the March paper. "This debunks previous thought that immunity by T cells only occurs at longer distances throughout the body." Skin-resident memory T cells provide efficient and long-lasting immunity against skin reinfection with the same virus, resulting in better antiviral protection in skin areas harbouring elevated numbers of these cells. It is proposed that the generation of large numbers of resident memory cells in these organs represents an important goal for future vaccination strategies. "Vaccines are of interest because we want to prevent the infection taking hold in the first place," said Dr Gebhardt. "This is especially important with the cold sore virus because while the immune response is developing against the initial infection, the virus can hide away in our nerve cells. The virus then remains dormant until the immune system is weakened by stress and the dreaded cold sore returns." The University of Melbourne ABN |
|||||||||||||||||||||
| Related Immune Cells Current Events and Immune Cells News Articles Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Scientists visualize how bacteria talk to one another Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. Genetic links to fungal infection risk identified Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments. Study shows how carbon nanotubes can affect lining of the lungs Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems. Manipulating Brain Inflammation May Help Clear Brain of Amyloid Plaques, Mayo Clinic Researchers Say In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease. Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease. New chromosomal abnormality identified in leukemia associated with Down syndrome Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome. More Immune Cells Current Events and Immune Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||